Therapeutic and imaging compositions and uses thereof

US2018258192A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018258192-A1
Application numberUS-201815978872-A
CountryUS
Kind codeA1
Filing dateMay 14, 2018
Priority dateMay 7, 2013
Publication dateSep 13, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various embodiments of the present invention are directed to polyrotaxanes comprising a poloxamer core and at least one cyclodextrin and methods for treating Niemann-Pick type C (NPC) and imaging (e.g., MRI) using the polyrotaxanes various embodiments of the present invention.

First claim

Opening claim text (preview).

1 . (canceled) 2 . A polyrotaxane comprising the general formula: or a salt thereof, wherein: n is an integer from 1 to 30; C and C′ are the same or different and represent endcapping groups of the formula wherein: is a (C 1 -C 6 )hydrocarbylene group, G 1 and G 2 , together, form a radical having the formula: wherein each L 2 is independently a bond acyl; each G 3 is a substituted or unsubstituted (C 6 -C 50 )hydrocarbyl group, interrupted by 0 to 5 groups chosen from —O—, —NH— and —S—; and each s is independently an integer from 1 to 5; and t is an integer from 2 to 5; B is a polyalkylene oxide polymer; and A is a beta cyclodextrin. 2 . The polyrotaxane of claim 2 , wherein G 3 substituted or unsubstituted —O—(C 6 -C 50 )alkyl group or a substituted or unsubstituted (C 6 -C 12 )aryl group. 3 . The polyrotaxane of claim 2 , wherein G 3 is a cholesteryl group. 4 . The polyrotaxane of claim 2 , where n is an integer from 5 to 15. 5 . The polyrotaxane of claim 2 , wherein n is an integer from 3 to 11. 6 . A pharmaceutical composition comprising the polyrotaxane of claim 2 and a pharmaceutically acceptable carrier.

Assignees

Inventors

Classifications

  • Antihyperlipidemics · CPC title

  • Polymers containing oxygen · CPC title

  • Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

  • Polyrotaxanes; Polycatenanes · CPC title

  • Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018258192A1 cover?
Various embodiments of the present invention are directed to polyrotaxanes comprising a poloxamer core and at least one cyclodextrin and methods for treating Niemann-Pick type C (NPC) and imaging (e.g., MRI) using the polyrotaxanes various embodiments of the present invention.
Who is the assignee on this patent?
Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification C08B37/0015. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).